The aim of the current study is to evaluate, in a prospective cross-over, randomized study, the effect of hyperbaric oxygen therapy (HBOT) on patients with chronic neurological deficits and cognitive impairment after anterior skull base meningioma tumor removal.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
62
HBOT of 2 ATA for 90 minutes, for 60 treatments
Assaf-Harofeh Medical Center
Ẕerifin, Israel
Neurocognitive functions
Cognitive function will be assessed using the one-hour Mindstreams Computerized Cognitive Test Battery at baseline, 3 months and 6 months to intervention.
Time frame: 6 months
Quality of Life
Quality of live will be evaluated by the EQ-5D questionnaire at baseline , 3 months and 6 months to intervention.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.